Abramson, Jeremy S.
Harvard Medical School,
United States
2025 Rank: 64039
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1805 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64039 | 69016 |
| Total Cites | 10213 | 11503 |
| H-index | 51 | 54 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 261 | 268 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 2665 | 2856 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3637 | 3952 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8355 | 9214 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.25 |
| Self-Citation Percentage |
11.21%
|
|
Abramson, Jeremy S.
Massachusetts General Hospital Cancer Center,
United States
2024 Rank: 76818
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2151 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76818 | 82853 |
| Total Cites | 8149 | 9225 |
| H-index | 47 | 51 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 220 | 227 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1996 | 2136 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 2874 | 3132 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6833 | 7576 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.22 |
| Self-Citation Percentage |
11.66%
|
|
Abramson, Jeremy S.
Harvard Medical School,
United States
2023 Rank: 98214
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2703 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98214 | 106502 |
| Total Cites | 6374 | 7253 |
| H-index | 43 | 46 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 163 | 170 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 1441 | 1548 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 2214 | 2427 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5500 | 6132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
12.12%
|
|
Abramson, Jeremy S.
Massachusetts General Hospital Cancer Center,
United States
2022 Rank: 135935
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5171 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 135935 | 144563 |
| Total Cites | 4810 | 5509 |
| H-index | 40 | 43 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 116 | 123 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 889 | 962 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 1561 | 1731 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4240 | 4770 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
12.69%
|
|